Severe kidney dysfunction in sialidosis mice reveals an essential role for neuraminidase 1 in reabsorption
Authors:
- Ikhui KhoIKIkhui Kho
- Ekaterina P. DeminaEDEkaterina P. Demina
- Xuefang PanXPXuefang Pan
- Irene LondonoILIrene Londono
- Christopher W. CairoChristopher W. Cairo
- Luisa SturialeLSLuisa Sturiale
- Angelo PalmigianoAPAngelo Palmigiano
- Angela MessinaAMAngela Messina
- Domenico GarozzoDGDomenico Garozzo
- Roth-Visal UngRURoth-Visal Ung
- Éric BonneilÉBÉric Bonneil
Open Access
- 23 October 2023
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 8 (20)
Abstract
Sialidosis is an ultra-rare multisystemic lysosomal disease caused by mutations in the neuraminidase 1 ( NEU1 ) gene. The severe type II form of the disease manifests with a prenatal/infantile or juvenile onset, bone abnormalities, severe neuropathology, and visceromegaly. A subset of these patients present with nephrosialidosis, characterized by abrupt onset of fulminant glomerular nephropathy. We studied the pathophysiological mechanism of the disease in 2 NEU1-deficient mouse models, a constitutive Neu1 -knockout, Neu1 ΔEx3 , and a conditional phagocyte-specific knockout, Neu1 Cx3cr1 Δ Ex3 . Mice of both strains exhibited terminal urinary retention and severe kidney damage with elevated urinary albumin levels, loss of nephrons, renal fibrosis, presence of storage vacuoles, and dysmorphic mitochondria in the intraglomerular and tubular cells. Glycoprotein sialylation in glomeruli, proximal distal tubules, and distal tubules was drastically increased, including that of an endocytic reabsorption receptor megalin. The pool of megalin bearing O-linked glycans with terminal galactose residues, essential for protein targeting and activity, was reduced to below detection levels. Megalin levels were severely reduced, and the protein was directed to lysosomes instead of the apical membrane. Together, our results demonstrated that desialylation by NEU1 plays a crucial role in processing and cellular trafficking of megalin and that NEU1 deficiency in sialidosis impairs megalin-mediated protein reabsorption.Keywords
Funding Information
- Canadian Institutes of Health Research (PJT-148863)
- Canadian Glycomics Network (CD-2)
- Canadian Glycomics Network (ID-01)
This publication has 77 references indexed in Scilit:
- Oligosaccharide Analysis in Urine by MALDI-TOF Mass Spectrometry for the Diagnosis of Lysosomal Storage DiseasesClinical Chemistry, 2013
- Renal phenotypic investigations of megalin-deficient patients: novel insights into tubular proteinuria and albumin filtration*Nephrology Dialysis Transplantation, 2012
- The Gne M712T Mouse as a Model for Human GlomerulopathyThe American Journal of Pathology, 2012
- Exposure of Thomsen-Friedenreich antigen in Streptococcus pneumoniae infection is dependent on pneumococcal neuraminidase AMicrobial Pathogenesis, 2011
- Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene listsNucleic Acids Research, 2008
- Sialic acids in human health and diseaseTrends in Molecular Medicine, 2008
- Neuraminidase 1 Is a Negative Regulator of Lysosomal ExocytosisDevelopmental Cell, 2008
- Mutation in the key enzyme of sialic acid biosynthesis causes severe glomerular proteinuria and is rescued by N-acetylmannosamineJournal of Clinical Investigation, 2007
- Thrombocytopenia and kidney disease in mice with a mutation in the C1galt1 geneProceedings of the National Academy of Sciences, 2006
- A severe infantile sialidosis: Clinical, biochemical, and microscopic featuresThe Journal of Pediatrics, 1980